» Articles » PMID: 23988414

Detection of Nodal Metastases by 18F-FDG PET/CT in Apparent Early Stage Ovarian Cancer: a Prospective Study

Overview
Journal Gynecol Oncol
Date 2013 Aug 31
PMID 23988414
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The rate of nodal metastases in ovarian cancer macroscopically confined to the pelvis is about 15%-20%. Systematic pelvic and aortic lymphadenectomy improves staging but it is associated with increased morbidity and costs. The purpose of this study was to evaluate the role of 18F-FDG PET/CT in the pre-operative nodal metastases detection in ovarian cancer grossly confined to the pelvis.

Methods: From 2006 to 2012, 68 consecutive women with epithelial ovarian cancer confined to the pelvis underwent 18F-FDG PET/CT followed by surgery inclusive of systematic pelvic and aortic lymphadenectomy (SAPL). 18F-FDG PET/CT images were analyzed and correlated to histological examination.

Results: Twenty-six women underwent bilateral and 42 unilateral SAPL with 3165 nodes removed and analyzed. Median number of dissected nodes was 42 (range 16-91). Twelve women (17.6%) had nodal metastases. 18F-FDG PET/CT correctly identified 10 patients with nodal involvement. Sensitivity, specificity, accuracy, positive and negative-predictive value of 18F-FDG PET/CT in detecting nodal metastases were 83.3%, 98.2%, 95.6%, 90.9% and 96.5%, respectively, on overall patient-based, and 75.5%, 99.4%, 98.1%, 87.5% and 98.6%, respectively, on nodal lesion site-based analysis.

Conclusion: 18F-FDG PET/CT is an accurate tool for the detection of nodal metastases. Metabolic imaging could be used to select women who could benefit from systematic lymphadenectomy. The high negative predictive value allows avoidance of SAPL in the vast majority of women, minimizing operative and post surgical complications. Further larger prospective investigation is required to confirm our data.

Citing Articles

Role of Positron Emission Tomography/Computed Tomography in Epithelial Ovarian Cancer.

Chandra R, Kumari S, Bhatla N, Kumar R, Tiwari A, Sachani H Indian J Nucl Med. 2024; 38(4):366-375.

PMID: 38390547 PMC: 10880854. DOI: 10.4103/ijnm.ijnm_42_22.


Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis.

Qi Y, Liu J, Wang X, Zhang Y, Li Z, Qi X J Ovarian Res. 2024; 17(1):48.

PMID: 38389075 PMC: 10882775. DOI: 10.1186/s13048-024-01375-7.


An evaluation of the physiological uptake range of F-fluoro-2-deoxy-D-glucose in normal ovaries of seven dogs using positron emission tomography/computed tomography.

Choi J, Chae Y, Kang B, Lee S Front Vet Sci. 2024; 11:1343695.

PMID: 38371597 PMC: 10869473. DOI: 10.3389/fvets.2024.1343695.


18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.

Allahqoli L, Hakimi S, Lagana A, Momenimovahed Z, Mazidimoradi A, Rahmani A J Imaging. 2023; 9(10).

PMID: 37888330 PMC: 10607780. DOI: 10.3390/jimaging9100223.


Predictive value of PET metabolic parameters for occult lymph node metastases in PET/CT defined node-negative patients with advanced epithelial ovarian cancer.

Xue B, Wang X Sci Rep. 2023; 13(1):9439.

PMID: 37296189 PMC: 10256759. DOI: 10.1038/s41598-023-36640-0.